MSB 3.21% $1.13 mesoblast limited

banter and General Discussion, page-10550

  1. 12,542 Posts.
    lightbulb Created with Sketch. 3394
    You’ve been very vocal & right on SI.
    As a CEO, he has performed so poorly…

    But, Mesoblast is as close to its first FDA approved product than ever in its lifecycle

    It’s hard to be in this dual state, I don’t like it - but here I am!

    Bring on the Ryoncil approval & I’ll be feeling much better

    GL MSB’ers - onwards & upwards!

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.